Search

everythinglearnresearchcommunity

for

Search:↓

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.

Early surgery reduces seizure risk in drug-resistant epilepsy; testosterone to DHT conversion doesn't affect muscle anabolism; veterans with PTSD likely to have riskier opioid use; bevacizumab helps in hereditary bleeding disorder.

Certain genes are linked to the risk of developing Alopecia Areata.

Obesity increases the risk of developing polycystic ovary syndrome, and weight loss can improve the condition.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

Certain liver diseases respond well to specific treatments and have varying risks for liver cancer.

PCOS may increase the risk of high blood pressure and heart issues.

Onions may help reduce cancer risk and obesity-related issues.

Endocrine-disrupting chemicals cause irreversible harm to children's development, increasing disease risk.

PCOS increases the risk of heart disease and type 2 diabetes in women.

Balding and low testosterone increase risk of urinary stones.

Inducing ferroptosis in hepatic stellate cells is crucial for treating liver fibrosis.

Finasteride may increase stroke risk in people with clotting tendencies.

IL6 is linked to higher risk of heart disease in people with a certain mouth condition.

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

Some birth control pills have a higher risk of blood clots than others.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Girls with PCOS during adolescence have a higher risk of developing type 2 diabetes, and early treatment can help manage this risk.

Women with PCOS may have a higher risk of respiratory and ear infections due to slower nasal mucociliary clearance.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

Women with PCOS have a higher risk of metabolic syndrome and need lifestyle changes and treatment.

Women with PCOS in Nigeria have higher heart risk markers, needing early heart health checks.

SNP rs2479106 in the DENND1A gene may increase PCOS risk in Saudi Arabian females.

Disrupting natural body clocks increases the risk of developing type 2 diabetes.

Exposure to plastics may increase the risk of irregular menstrual cycles and symptoms of hormone imbalance in teenage girls.

PCOS treatment should address both symptoms and metabolic risks, starting with lifestyle changes and possibly including medication.